Early research (Phase 1)Study completedNCT00505401What this trial is testingPhase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDSWho this might be right forHIV Infections Istituto Superiore di Sanità 27
Post-approval studies (Phase 4)Study completedNCT04054492What this trial is testingTo Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPVWho this might be right forVaccinationReaction - Vaccine China National Biotec Group Company Limited 604
Testing effectiveness (Phase 2)Study completedNCT00004211What this trial is testingVaccine Therapy in Treating Patients With Metastatic Prostate CancerWho this might be right forProstate Cancer Duke University 17
Early research (Phase 1)Study completedNCT00121771What this trial is testingMalaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian MenWho this might be right forMalaria London School of Hygiene and Tropical Medicine 32
Early research (Phase 1)Not Yet RecruitingNCT07557602What this trial is testingMRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young AdultsWho this might be right forEBV Vaccine Company, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT04969601What this trial is testingAnti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsWho this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 76
Post-approval studies (Phase 4)Study completedNCT01069367What this trial is testingOpen-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly SubjectsWho this might be right forSwine-Origin Influenza A H1N1 Virus Novartis Vaccines 100
Large-scale testing (Phase 3)Study completedNCT00871000What this trial is testingImmunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.Who this might be right forAcellular PertussisTetanusDiphtheria+1 more GlaxoSmithKline 303
Large-scale testing (Phase 3)Study completedNCT01462357What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old FemalesWho this might be right forInfections, Papillomavirus GlaxoSmithKline 1,079
Testing effectiveness (Phase 2)Study completedNCT05412030What this trial is testingEvaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsWho this might be right forPneumonia, BacterialPneumococcal InfectionsPneumonia, Pneumococcal GlaxoSmithKline 388
Large-scale testing (Phase 3)Study completedNCT04386707What this trial is testingLot-consistency Clinical Trial of Sabin Strain Inactivated Polio VaccineWho this might be right forPoliomyelitis Sinovac Biotech Co., Ltd 1,300
Early research (Phase 1)Study completedNCT02601612What this trial is testingSafety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and ChildrenWho this might be right forRespiratory Syncytial Virus Infections National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT01681992What this trial is testingImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeWho this might be right forMeaslesMumpsRubella+1 more GlaxoSmithKline 4,538
Large-scale testing (Phase 3)Ended earlyNCT04544267What this trial is testingStudy on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 100
Testing effectiveness (Phase 2)Study completedNCT05575492What this trial is testingMRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of AgeWho this might be right forCytomegalovirus ModernaTX, Inc. 873
Early research (Phase 1)Study completedNCT02533791What this trial is testingA Booster Dose of Ad5-EBOV in Healthy Adults After Primary ImmunizationWho this might be right forEbola Virus Disease Jiangsu Province Centers for Disease Control and Prevention 110
Testing effectiveness (Phase 2)Study completedNCT00652223What this trial is testingEffect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite AllergyWho this might be right forPerennial Allergic RhinoconjunctivitisAllergic Asthma Cytos Biotechnology AG 21
Testing effectiveness (Phase 2)Looking for participantsNCT07582796What this trial is testingClinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.Who this might be right forRespiratory Syncytial Virus Infections Ab&B Bio-tech Co., Ltd.JS 470
Early research (Phase 1)Study completedNCT02839161What this trial is testingStudy of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese ChildrenWho this might be right forHookworm DiseaseHookworm Infection Baylor College of Medicine 60
Testing effectiveness (Phase 2)UnknownNCT04444674What this trial is testingCOVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infectionWho this might be right forCoronavirus University of Oxford 2,130